<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: An easily accessible and valid surrogate marker for interventional <z:hpo ids='HP_0001297'>stroke</z:hpo> trials is needed </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To investigate the usefulness of various S100B serum measures to predict long-term outcome and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Inception cohort study </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Tertiary care university hospital </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS: Thirty-nine patients (mean +/- SD age, 69.1 +/- 11.5 years) with <z:hpo ids='HP_0011009'>acute</z:hpo> nonlacunar <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> presenting less than 6 hours after symptom <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: Functional outcome 6 months after <z:hpo ids='HP_0001297'>stroke</z:hpo> (modified Rankin scale score) and final <z:mpath ids='MPATH_124'>infarct</z:mpath> volume on day 7 by means of standardized volumetry of brain images </plain></SENT>
<SENT sid="6" pm="."><plain>Serum S100B level was determined at hospital admission and 24, 48, 72, 96, 120, and 144 hours after symptom <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Single S100B measures obtained 48 and 72 hours after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> demonstrated the highest Spearman rank correlations with modified Rankin scale scores (rho = 0.68 and rho = 0.67, respectively; P&lt;.001) and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (rho = 0.95 and rho = 0.94, respectively; P&lt;.001) </plain></SENT>
<SENT sid="8" pm="."><plain>A 48-hour S100B value of 0.37 microg/L or less revealed a sensitivity of 0.87 and a specificity of 0.78 in predicting an independent functional outcome </plain></SENT>
<SENT sid="9" pm="."><plain>In a multivariate model, S100B emerged as an outcome predictor that was independent of age, sex, <z:hpo ids='HP_0001297'>stroke</z:hpo> severity, etiology, lesion side, and risk factors </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Single S100B values obtained 48 and 72 hours after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> provide the highest predictive values with respect to functional outcome and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in nonlacunar <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>More complex measures of the S100B kinetic (ie, area under the curve or peak value) were not superior </plain></SENT>
<SENT sid="12" pm="."><plain>Therefore, these single S100B measures appear to be useful surrogate end points in <z:hpo ids='HP_0011009'>acute</z:hpo> interventional <z:hpo ids='HP_0001297'>stroke</z:hpo> trials </plain></SENT>
</text></document>